Christine John
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 09, 2025
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R).
Journal: European journal of gastroenterology & hepatology
Published: September 21, 2020
Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry.
Journal: European journal of gastroenterology & hepatology
Published: April 30, 2020
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R).
Journal: Zeitschrift fur Gastroenterologie
Published: February 11, 2020
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-Registry.
Journal: Alimentary pharmacology & therapeutics
Published: December 19, 2018
A peptide extension dictates IgM assembly.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 05, 2017
A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
Journal: The Journal of biological chemistry
Published: May 19, 2017
Determinants of the assembly and function of antibody variable domains.
Journal: Scientific reports
Published: February 23, 2017
Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90.
Journal: Journal of molecular biology
Published: June 02, 2016
Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.
Journal: PloS one
Published: May 19, 2016
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 11, 2016
Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation.
Journal: JACC. Basic to translational science
Published: January 26, 2016
Last Updated: 09/26/2026